These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8978935)

  • 1. Cholinesterase inhibition improves blood flow in the ischemic cerebral cortex.
    Scremin OU; Li MG; Scremin AM; Jenden DJ
    Brain Res Bull; 1997; 42(1):59-70. PubMed ID: 8978935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolonged effects of cholinesterase inhibition with eptastigmine on the cerebral blood flow-metabolism ratio of normal rats.
    Scremin OU; Scremin AM; Heuser D; Hudgell R; Romero E; Imbimbo BP
    J Cereb Blood Flow Metab; 1993 Jul; 13(4):702-11. PubMed ID: 8314923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies.
    Braida D; Sala M
    CNS Drug Rev; 2001; 7(4):369-86. PubMed ID: 11830755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physostigmine induced reversal of ischemia following acute middle cerebral artery occlusion in the rat.
    Scremin OU; Scremin AM
    Stroke; 1986; 17(5):1004-9. PubMed ID: 3764945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cyclic AMP-dependent protein kinase in the acute phase of focal cerebral ischemia in the rat.
    Tanaka K; Nogawa S; Nagata E; Suzuki S; Dembo T; Kosakai A; Fukuuchi Y
    Neuroscience; 1999; 94(2):361-71. PubMed ID: 10579200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic modulation of cerebral cortical blood flow changes induced by trauma.
    Scremin OU; Li MG; Jenden DJ
    J Neurotrauma; 1997 Aug; 14(8):573-86. PubMed ID: 9300567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CO2 reactivity and heterogeneity of cerebral blood flow in ischemic, border zone, and normal cortex.
    Jones SC; Bose B; Furlan AJ; Friel HT; Easley KA; Meredith MP; Little JR
    Am J Physiol; 1989 Aug; 257(2 Pt 2):H473-82. PubMed ID: 2504058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heptyl-physostigmine enhances basal forebrain control of cortical cerebral blood flow.
    Linville DG; Giacobini E; Arnerić SP
    J Neurosci Res; 1992 Mar; 31(3):573-7. PubMed ID: 1640506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamics and pharmacokinetics of eptastigmine in elderly subjects.
    Auteri A; Mosca A; Lattuada N; Luzzana M; Zecca L; Radice D; Imbimbo BP
    Eur J Clin Pharmacol; 1993; 45(4):373-6. PubMed ID: 8299673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed administration of ethyl eicosapentate improves local cerebral blood flow and metabolism without affecting infarct volumes in the rat focal ischemic model.
    Katsumata T; Katayama Y; Obo R; Muramatsu H; Ohtori T; Terashi A
    Eur J Pharmacol; 1999 May; 372(2):167-74. PubMed ID: 10395096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinesterase inhibitors increase secretion of APPs in rat brain cortex.
    Mori F; Lai CC; Fusi F; Giacobini E
    Neuroreport; 1995 Mar; 6(4):633-6. PubMed ID: 7605915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-acting cholinesterase inhibitor heptyl-physostigmine attenuates the scopolamine-induced learning impairment of rats in a 14-unit T-maze.
    Iijima S; Greig NH; Garofalo P; Spangler EL; Heller B; Brossi A; Ingram DK
    Neurosci Lett; 1992 Sep; 144(1-2):79-83. PubMed ID: 1436716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physostigmine enhances blood flow-metabolism ratio in neocortex.
    Scremin OU; Allen K; Torres C; Scremin AM
    Neuropsychopharmacology; 1988 Dec; 1(4):297-303. PubMed ID: 3150807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fentanyl pretreatment on regional cerebral blood flow in focal cerebral ischemia in rats.
    Chi OZ; Hunter C; Liu X; Chokshi SK; Weiss HR
    Pharmacology; 2010; 85(3):153-7. PubMed ID: 20150753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between pharmacokinetics and pharmacodynamics of eptastigmine in young healthy volunteers.
    Imbimbo BP; Licini M; Schettino M; Mosca A; Onelli E; Zecca L; Giustina A
    J Clin Pharmacol; 1995 Mar; 35(3):285-90. PubMed ID: 7608318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximum tolerated dose and pharmacodynamics of eptastigmine in elderly healthy volunteers.
    Mant T; Troetel WM; Imbimbo BP
    J Clin Pharmacol; 1998 Jul; 38(7):610-7. PubMed ID: 9702845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of the blood flow response to physostigmine in the rat cortex deafferented from the basal forebrain.
    Peruzzi P; Von Euw D; Corrèze JL; Lacombe P
    Brain Res Bull; 2007 Apr; 72(1):66-73. PubMed ID: 17303509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiated cerebrovascular effects of physostigmine and tacrine in cortical areas deafferented from the nucleus basalis magnocellularis suggest involvement of basalocortical projections to microvessels.
    Peruzzi P; von Euw D; Lacombe P
    Ann N Y Acad Sci; 2000 Apr; 903():394-406. PubMed ID: 10818530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptors mediate attenuation of extracellular acetylcholine levels in rat cerebral cortex after cholinesterase inhibition.
    Messamore E; Warpman U; Williams E; Giacobini E
    Neurosci Lett; 1993 Aug; 158(2):205-8. PubMed ID: 8233096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional cerebral ischemia in the gerbil: measurement of regional cerebral blood flow by quantitative autoradiography.
    Yoshimine T; Hayakawa T; Yamada K; Takemoto O; Kato A; Ushio Y; Mogami H
    J Cereb Blood Flow Metab; 1986 Jun; 6(3):348-57. PubMed ID: 3711162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.